The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Genomic analysis of hepatoblastoma identifies distinct molecular and prognostic subgroups
Open accessAbstract
Despite being the most common liver cancer in children, hepatoblastoma (HB) is a rare neoplasm. Consequently, few pretreatment tumors have been molecularly profiled, and there are no validated prognostic or therapeutic biomarkers for HB patients. We report on the first large-scale effort to profile pretreatment HBs at diagnosis. Our analysis of 88 clinically annotated HBs revealed three risk-stratifying molecular subtypes that are characterized by differential activation of hepatic progenitor cell markers and metabolic pathways: high-risk tumors were characterized by up-regulated nuclear factor, erythroid 2-like 2 activity; high lin-28 homolog B, high mobility group AT-hook 2, spalt-like transcription factor 4, and alpha-fetoprotein expression; and high coordinated expression of oncofetal proteins and stem-cell markers, while low-risk tumors had low lin-28 homolog B and lethal-7 expression and high hepatic nuclear factor 1 alpha activity. CONCLUSION: Analysis of immunohistochemical assays using antibodies targeting these genes in a prospective study of 35 HBs suggested that these candidate biomarkers have the potential to improve risk stratification and guide treatment decisions for HB patients at diagnosis; our results pave the way for clinical collaborative studies to validate candidate biomarkers and test their potential to improve outcome for HB patients. (Hepatology 2017;65:104-121).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Finding groups in data: an introduction to cluster analysis
(1991) · Choice Reviews Online · doi:10.5860/choice.28-4558 · Cited by 10,474
Finding Groups in Data: An Introduction to Cluster Analysis
Kaufman, L., & Rousseeuw, P. J. (1990) · Wiley Series in Probability and Statistics · doi:10.1002/9780470316801 · Cited by 7,344
Estimating the Number of Clusters in a Data Set Via the Gap Statistic
Tibshirani, R., Walther, G., & Hastie, T. (2001) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/1467-9868.00293 · Cited by 6,205
COSMIC: exploring the world's knowledge of somatic mutations in human cancer
Forbes, S. A., Beare, D., Gunasekaran, P., Leung, K., Bindal, N., Boutselakis, H., Ding, M., Bamford, S., Cole, C., Ward, S., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku1075 · Cited by 2,283
Guichard, C., Amaddeo, G., Imbeaud, S., Ladeiro, Y., Pelletier, L., Maad, I. B., Calderaro, J., Bioulac-Sage, P., Letexier, M., Degos, F., et al. (2012) · Nature Genetics · doi:10.1038/ng.2256 · Cited by 1,453
Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model
Kota, J., Chivukula, R. R., O'Donnell, K. A., Wentzel, E. A., Montgomery, C. L., Hwang, H.-W., Chang, T.-C., Vivekanandan, P., Torbenson, M., Clark, K. R., et al. (2009) · Cell · doi:10.1016/j.cell.2009.04.021 · Cited by 1,452
Molecular Findings Among Patients Referred for Clinical Whole-Exome Sequencing
Yang, Y., Muzny, D. M., Xia, F., Niu, Z., Person, R., Ding, Y., Ward, P., Braxton, A., Wang, M., Buhay, C., et al. (2014) · JAMA · doi:10.1001/jama.2014.14601 · Cited by 1,360
Roush, S., & Slack, F. J. (2008) · Trends in Cell Biology · doi:10.1016/j.tcb.2008.07.007 · Cited by 1,328
Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets
Boyault, S., Rickman, D. S., de Reyniès, A., Balabaud, C., Rebouissou, S., Jeannot, E., Hérault, A., Saric, J., Belghiti, J., Franco, D., et al. (2007) · Hepatology · doi:10.1002/hep.21467 · Cited by 1,258
TRANSFAC: an integrated system for gene expression regulation
Wingender, E. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.316 · Cited by 1,239
The genetic landscape of high-risk neuroblastoma
Pugh, T. J., Morozova, O., Attiyeh, E. F., Asgharzadeh, S., Wei, J. S., Auclair, D., Carter, S. L., Cibulskis, K., Hanna, M., Kiezun, A., et al. (2013) · Nature Genetics · doi:10.1038/ng.2529 · Cited by 1,186
A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells
Lee, J.-S., Heo, J., Libbrecht, L., Chu, I.-S., Kaposi-Novak, P., Calvisi, D. F., Mikaelyan, A., Roberts, L. R., Demetris, A. J., Sun, Z., et al. (2006) · Nature Medicine · doi:10.1038/nm1377 · Cited by 953
Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2
Wang, X.-J., Sun, Z., Villeneuve, N. F., Zhang, S., Zhao, F., Li, Y., Chen, W., Yi, X., Zheng, W., Wondrak, G. T., et al. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn095 · Cited by 839
Zucman-Rossi, J., Jeannot, E., Van Nhieu, J. T., Scoazec, J.-Y., Guettier, C., Rebouissou, S., Bacq, Y., Leteurtre, E., Paradis, V., Michalak, S., et al. (2006) · Hepatology · doi:10.1002/hep.21068 · Cited by 760
Focal Gains of VEGFA and Molecular Classification of Hepatocellular Carcinoma
Chiang, D. Y., Villanueva, A., Hoshida, Y., Peix, J., Newell, P., Minguez, B., LeBlanc, A. C., Donovan, D. J., Thung, S. N., Solé, M., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0742 · Cited by 719
EpCAM and α-Fetoprotein Expression Defines Novel Prognostic Subtypes of Hepatocellular Carcinoma
Yamashita, T., Forgues, M., Wang, W., Kim, J. W., Ye, Q., Jia, H., Budhu, A., Zanetti, K. A., Chen, Y., Qin, L.-X., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6013 · Cited by 717
Self-citationLin28A and Lin28B Inhibit let-7 MicroRNA Biogenesis by Distinct Mechanisms
Piskounova, E., Polytarchou, C., Thornton, J. E., LaPierre, R. J., Pothoulakis, C., Hagan, J. P., Iliopoulos, D., & Gregory, R. I. (2011) · Cell · doi:10.1016/j.cell.2011.10.039 · Cited by 612
Cairo, S., Armengol, C., De Reyniès, A., Wei, Y., Thomas, E., Renard, C.-A., Goga, A., Balakrishnan, A., Semeraro, M., Gresh, L., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.11.002 · Cited by 509
Regulatory phases of early liver development: paradigms of organogenesis
Zaret, K. S. (2002) · Nature Reviews Genetics · doi:10.1038/nrg837 · Cited by 508
Koch, A., Denkhaus, D., Albrecht, S., Leuschner, I., von Schweinitz, D., & Pietsch, T. (1999) · PubMed · Cited by 399
CLICK and EXPANDER: a system for clustering and visualizing gene expression data
Sharan, R., Maron-Katz, A., & Shamir, R. (2003) · Bioinformatics · doi:10.1093/bioinformatics/btg232 · Cited by 370
López-Terrada, D., Alaggio, R., de Dávila, M. T., Czauderna, P., Hiyama, E., Katzenstein, H., Leuschner, I., Malogolowkin, M., Meyers, R., Ranganathan, S., et al. (2014) · Modern Pathology · doi:10.1038/modpathol.2013.80 · Cited by 355
Self-citationCopley, M. R., Babovic, S., Benz, C., Knapp, D. J. H. F., Beer, P. A., Kent, D. G., Wohrer, S., Treloar, D. Q., Day, C., Rowe, K., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2783 · Cited by 342
Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas†
Luo, J., Ren, B., Keryanov, S., Tseng, G. C., Rao, U. N. M., Monga, S. P., Strom, S., Demetris, A. J., Nalesnik, M., Yu, Y. P., et al. (2006) · Hepatology · doi:10.1002/hep.21328 · Cited by 339
The epidemiology of hepatoblastoma
Spector, L. G., & Birch, J. (2012) · Pediatric Blood & Cancer · doi:10.1002/pbc.24215 · Cited by 328
Tao, J., Calvisi, D. F., Ranganathan, S., Cigliano, A., Zhou, L., Singh, S., Jiang, L., Fan, B., Terracciano, L., Armeanu–Ebinger, S., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.05.004 · Cited by 317
Hepatoblastoma state of the art: pathology, genetics, risk stratification, and chemotherapy
Czauderna, P., Lopez-Terrada, D., Hiyama, E., Häberle, B., Malogolowkin, M. H., & Meyers, R. L. (2014) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000046 · Cited by 306
Self-citationOncofetal Gene SALL4 in Aggressive Hepatocellular Carcinoma
Yong, K. J., Gao, C., Lim, J. S. J., Yan, B., Yang, H., Dimitrov, T., Kawasaki, A., Ong, C. W., Wong, K.-F., Lee, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1300297 · Cited by 257
The genomic landscape of hepatoblastoma and their progenies with HCC-like features
Eichenmüller, M., Trippel, F., Kreuder, M., Beck, A., Schwarzmayr, T., Häberle, B., Cairo, S., Leuschner, I., von Schweinitz, D., Strom, T. M., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.08.009 · Cited by 250
Battle, M. A., Konopka, G., Parviz, F., Gaggl, A. L., Yang, C., Sladek, F. M., & Duncan, S. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600246103 · Cited by 246
Takayama, K., Inamura, M., Kawabata, K., Katayama, K., Higuchi, M., Tashiro, K., Nonaka, A., Sakurai, F., Hayakawa, T., Kusuda Furue, M., et al. (2012) · Molecular Therapy · doi:10.1038/mt.2011.234 · Cited by 235
Reid, J. G., Carroll, A., Veeraraghavan, N., Dahdouli, M., Sundquist, A., English, A., Bainbridge, M., White, S., Salerno, W., Buhay, C., et al. (2014) · BMC Bioinformatics · doi:10.1186/1471-2105-15-30 · Cited by 221
Trobaugh‐Lotrario, A. D., Tomlinson, G. E., Finegold, M. J., Gore, L., & Feusner, J. H. (2009) · Pediatric Blood & Cancer · doi:10.1002/pbc.21834 · Cited by 171
Self-citationPendás-Franco, N., García, J. M., Peña, C., Valle, N., Pálmer, H. G., Heinäniemi, M., Carlberg, C., Jiménez, B., Bonilla, F., Muñoz, A., et al. (2008) · Oncogene · doi:10.1038/onc.2008.88 · Cited by 171
Molecular Biology of Liver Cancer Stem Cells
Oishi, N., Yamashita, T., & Kaneko, S. (2014) · Liver Cancer · doi:10.1159/000343863 · Cited by 169
López-Terrada, D., Gunaratne, P. H., Adesina, A. M., Pulliam, J., Hoang, D. M., Nguyen, Y., Mistretta, T.-A., Margolin, J., & Finegold, M. J. (2009) · Human Pathology · doi:10.1016/j.humpath.2008.07.022 · Cited by 163
Self-citationElevated Expression of Wnt Antagonists Is a Common Event in Hepatoblastomas
Koch, A., Waha, A., Hartmann, W., Hrychyk, A., Schüller, U., Waha, A., Wharton, K. A., Fuchs, S. Y., Schweinitz, D. V., & Pietsch, T. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1162 · Cited by 158
Servitja, J., Pignatelli, M., Maestro, M. Á., Cardalda, C. A., Boj, S. F., Lozano, J. J., Blanco, E., Lafuente, A., McCarthy, M. I., Sumoy, L., et al. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01389-08 · Cited by 145
Reznik, Y., Dao, T., Coutant, R., Chiche, L., Jeannot, E., Clauin, S., Rousselot, P., Fabrè, M., Oberti, F., Fatome, A., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031552 · Cited by 140
Tomlinson, G. E., Douglass, E. C., Pollock, B. H., Finegold, M. J., & Schneider, N. R. (2005) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20227 · Cited by 89
Self-citationCancer stem cells in hepatocellular carcinoma: Recent progress and perspective
Chiba, T., Kamiya, A., Yokosuka, O., & Iwama, A. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.04.027 · Cited by 80
Adesina, A. M., Lopez-Terrada, D. H., Wong, K., Gunaratne, P. H., Nguyen, Y., Pulliam, J. F., Margolin, J., & Finegold, M. J. (2009) · Human Pathology · doi:10.1016/j.humpath.2008.10.022 · Cited by 78
Self-citationDickkopfs and Wnt/β-catenin signalling in liver cancer
Fatima, S., Lee, N. P. Y., & Luk, J. M. (2011) · World Journal of Clinical Oncology · doi:10.5306/wjco.v2.i8.311 · Cited by 60
Cheng, S.-W., Tsai, H.-W., Lin, Y.-J., Cheng, P., Chang, Y., Yen, C.-J., Huang, H.-P., Chuang, Y.-P., Chang, T., Lee, C., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080053 · Cited by 57
Oncofetal Gene SALL4 in Aggressive Hepatocellular Carcinoma
Yong, K. J., Chai, L., & Tenen, D. G. (2013) · New England Journal of Medicine · doi:10.1056/nejmc1308785 · Cited by 55
Becker, D., Sfakianakis, I., Krupp, M., Staib, F., Gerhold‐Ay, A., Victor, A., Binder, H., Blettner, M., Maass, T., Thorgeirsson, S. S., et al. (2012) · Molecular Cancer · doi:10.1186/1476-4598-11-55 · Cited by 32
A Systems Biology Approach to Transcription Factor Binding Site Prediction
Zhou, X., Sumazin, P., Rajbhandari, P., & Califano, A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009878 · Cited by 16
Self-citationAlvarez, M. J., Sumazin, P., Rajbhandari, P., & Califano, A. (2009) · Genome biology · doi:10.1186/gb-2009-10-12-r143 · Cited by 15
Self-citation
Cited by
The Curious Case of the HepG2 Cell Line: 40 Years of Expertise
Arzumanian, V. A., Kiseleva, O. I., & Poverennaya, E. V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222313135 · Cited by 387
Rewiring lipid metabolism by targeting PCSK9 and HMGCR to treat liver cancer
Alannan, M., Trézéguet, V., Amoêdo, N. D., Rossignol, R., Mahfouf, W., Rezvani, H. R., Dittrich-Domergue, F., Moreau, P., Lacomme, S., Gontier, E., et al. (2022) · Cancers · doi:10.3390/cancers15010003 · Cited by 25
Metadata
- Authors
- Sumazin, P., Chen, Y., Treviño, L. R., Sarabia, S. F., Hampton, O. A., Patel, K., Mistretta, T., Zorman, B., Thompson, P., Heczey, A., Comerford, S., Wheeler, D. A., Chintagumpala, M., Meyers, R., Rakheja, D., Finegold, M. J., Tomlinson, G., Parsons, D. W., & López‐Terrada, D.
- Venue
- Hepatology
- Published
- 2017-01
- Volume
- 65
- Issue
- 1
- Pages
- 104-121
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2536314181
- Cited by
- 258
- References
- 49
- FWCI
- 10.32
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.